Periods | Age | PI level | Total | |||
---|---|---|---|---|---|---|
Group | Low | Total | Med-High | High | ||
P1-P2 | 65–69 | − 3.78% | 4.07% | 4.34% | −7.67% | 3.12% |
70–74 | 3.15% | 5.45% | 2.35% | 7.52% | 6.04% | |
75–79 | 9.47% | 11.28% | 4.70% | 3.43% | 8.34% | |
80–84 | 7.46% | 7.74% | 8.94% | 16.11% | 8.55% | |
85+ | −4.22% | −3.90% | 0.99% | 9.47% | −0.07% | |
Total | 1.58% | 1.98% | 4.31% | 7.50% | 4.01% | |
P2-P3 | 65–69 | −11.56% | −12.97% | −5.99% | 6.37% | −6.64% |
70–74 | −8.00% | 2.81% | 2.82% | 8.63% | 4.70% | |
75–79 | −4.63% | −1.60% | 6.61% | 14.05% | 5.23% | |
80–84 | 2.52% | 0.83% | 7.04% | 1.47% | 3.39% | |
85+ | 6.61% | 3.98% | 10.85% | 5.31% | 6.86% | |
Total | 1.41% | 1.79% | 6.90% | 7.22% | 4.95% | |
P1-P3 | 65–69 | −15.78% | −8.38% | −1.39% | −0.81% | − 3.31% |
70–74 | −4.60% | 8.10% | 5.11% | 15.50% | 10.45% | |
75–79 | 5.29% | 9.86% | 11.00% | 16.99% | 13.13% | |
80–84 | 9.79% | 8.50% | 15.35% | 17.34% | 11.65% | |
85+ | 2.67% | 0.24% | 11.73% | 14.27% | 6.80% | |
Total | 2.97% | 3.73% | 10.91% | 14.18% | 8.76% |